Brief: Agile Therapeutics Says On May 11 Timely Submitted Its Plan To Staff Of Nasdaq To Regain Compliance With Nasdaq Listing Rule 5550(B)(1)

Agile Therapeutics

17/05/2023 12:37

May 17 (Reuters) - Agile Therapeutics Inc  AGRX.O :
    * AGILE THERAPEUTICS - ON MAY 11 TIMELY SUBMITTED ITS PLAN
TO
STAFF OF NASDAQ TO REGAIN COMPLIANCE WITH NASDAQ LISTING RULE
5550(B)(1)
    * AGILE THERAPEUTICS INC - COMPLIANCE PLAN IS CURRENTLY
UNDER
REVIEW BY NASDAQ STAFF

Source text for Eikon:  ID: 
Further company coverage:  AGRX.O 

 ((Reuters.Brief@thomsonreuters.com;))